Stay updated on Oral Immunotherapy for Peanut Allergic Patients Clinical Trial

Sign up to get notified when there's something new on the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The only visible change is a revision label updated from v3.3.1 to v3.3.2 in the page footer, with no changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:28:24.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T14:39:41.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:42:19.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and updated timestamps were observed on the Study Details page, without changes to the core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:14:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T10:08:53.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Update to revision tag (v3.1.0) and an added numeric line; removal of several drug-safety topic links (e.g., Drug Safety, Counterfeit Drugs, Substandard Drugs) and related categories (Pharmaceutical Preparations).
    Difference
    0.7%
    Check dated 2025-09-28T03:15:17.000Z thumbnail image

Stay in the know with updates to Oral Immunotherapy for Peanut Allergic Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page.